ORCL Stock Analysis: Oracle | NYSE
Software - Infrastructure | NYSE, USA | Market Cap: 455.344m USD | 12M Return: -54% | US68389X1054 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.10B
EPS Trend: 95.7%
Qual. Beats: 2
Rev. Trend: 96.5%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Oracle Corporation (NYSE: ORCL) is an enterprise software and cloud computing company that provides a broad portfolio of products spanning software-as-a-service (SaaS), cloud and on-premise licenses, infrastructure technologies, and hardware. Its cloud applications cover core business functions including enterprise resource planning (ERP), supply chain management, human capital management, financial performance, customer experience, and healthcare, alongside industry-specific solutions. The company also sells database and middleware technologies, including the Oracle Database, MySQL, and Java, as well as engineered hardware systems, storage, and related support and consulting services.
Oracle operates primarily in the Information Technology sector (GICS Sub Industry: Systems Software), serving businesses, government agencies, and educational institutions through both direct sales and indirect channels. Founded in 1977 and headquartered in Austin, Texas, Oracle has been publicly traded since its 1986 IPO and maintains a strategic alliance with Metron, Inc. Its business model is anchored in recurring revenue from cloud subscriptions and license support, supplemented by hardware sales and professional services.
- OCI cloud revenue accelerates on AI workload demand
- Legacy database license revenue continues declining
- Cerner healthcare segment margins face ongoing pressure
| Net Income: 18.9b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -6.21 > 1.0 |
| NWC/Revenue: 11.31% < 20% (prev -25.82%; Δ 37.13% < -1%) |
| CFO/TA 0.15 > 3% & CFO 46.9b > Net Income 18.9b |
| Net Debt (149b) to EBITDA (37.7b): 3.96 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.00b) vs 12m ago 3.13% < -2% |
| Gross Margin: 63.95% > 18% (prev 69.66%; Δ -5.72% > 0.5%) |
| Asset Turnover: 29.68% > 50% (prev 32.71%; Δ -3.03% > 0%) |
| Interest Coverage Ratio: 5.26 > 6 (EBIT TTM 26.8b / Interest Expense TTM 5.10b) |
| A: 0.03 (Total Current Assets 55.6b - Total Current Liabilities 47.5b) / Total Assets 303b |
| B: -0.00 (Retained Earnings -1.11b / Total Assets 303b) |
| C: 0.11 (EBIT TTM 26.8b / Avg Total Assets 242b) |
| D: 0.28 (Book Value of Equity 66.8b / Total Liabilities 236b) |
| Altman-Z'' = 1.21 = BB |
| DSRI: 1.06 (Receivables 11.4b/8.84b, Revenue 71.8b/59.0b) |
| GMI: 1.09 (GM 69.66% / 63.95%) |
| AQI: 0.50 (AQ_t 0.28 / AQ_t-1 0.57) |
| SGI: 1.22 (Revenue 71.8b / 59.0b) |
| TATA: -0.09 (NI 18.9b - CFO 46.9b) / TA 303b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of September 23, 2026, the stock is trading at USD 149.20 with a total of 30,813,324 shares traded. Over the past week, the price has changed by +6.31%, over one month by +4.74%, over three months by -14.48% and over the past year by -54.01%.
Current recommended Stop Loss: 132.10 (which is 11.5% or 2.3 ATR below the current price).
Oracle has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy ORCL.
- StrongBuy: 20
- Buy: 4
- Hold: 15
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 239 | 60.2% |
P/E Trailing = 22.4092
P/E Forward = 17.6367
P/S = 6.344
P/B = 7.0025
P/EG = 0.8019
Revenue TTM = 71.8b USD
EBIT TTM = 26.8b USD
EBITDA TTM = 37.7b USD
Long Term Debt = 118b USD (from longTermDebt, last quarter)
Short Term Debt = 7.62b USD (from shortTermDebt, last quarter)
Debt = 187b USD (from shortLongTermDebtTotal, last quarter) + Leases 30.6b
Net Debt = 149b USD (calculated: Debt 187b - CCE 37.1b)
Enterprise Value = 605b USD (455b + Debt 187b - CCE 37.1b)
Interest Coverage Ratio = 5.26 (Ebit TTM 26.8b / Interest Expense TTM 5.10b)
EV/FCF = -21.06x (Enterprise Value 605b / FCF TTM -28.7b)
FCF Yield = -4.75% (FCF TTM -28.7b / Enterprise Value 605b)
FCF Margin = -40.01% (FCF TTM -28.7b / Revenue TTM 71.8b)
Net Margin = 26.36% (Net Income TTM 18.9b / Revenue TTM 71.8b)
Gross Margin = 63.95% ((Revenue TTM 71.8b - Cost of Revenue TTM 25.9b) / Revenue TTM)
Gross Margin QoQ = 60.03% (prev 65.18%)
Tobins Q-Ratio = 1.99 (Enterprise Value 605b / Total Assets 303b)
Interest Expense / Debt = 2.74% (Interest Expense 5.10b / Debt 187b)
Taxrate = 12.92% (2.81b / 21.8b)
NOPAT = 23.4b (EBIT 26.8b * (1 - 12.92%))
Current Ratio = 1.17 (Total Current Assets 55.6b / Total Current Liabilities 47.5b)
Debt / Equity = 2.79 (Debt 187b / totalStockholderEquity, last quarter 66.8b)
Debt / EBITDA = 3.96 (Net Debt 149b / EBITDA 37.7b)
Debt / FCF = -5.20 (negative FCF - burning cash) (Net Debt 149b / FCF TTM -28.7b)
Total Stockholder Equity = 44.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.82% (Net Income 18.9b / Total Assets 303b)
RoE = 42.58% (Net Income TTM 18.9b / Total Stockholder Equity 44.4b)
RoCE = 16.55% (EBIT 26.8b / Capital Employed (Equity 44.4b + L.T.Debt 118b))
RoIC = 9.00% (NOPAT 23.4b / Invested Capital 260b)
WACC = 10.68% (E(455b)/V(642b) * Re(14.08%) + D(187b)/V(642b) * Rd(2.74%) * (1-Tc(0.13)))
Discount Rate = 14.08% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 91.31 | Cagr: 2.56%
[DCF] Fair Price = unknown (Cash Flow -28.7b)
EPS Correlation: 95.66 | EPS CAGR: 13.00% | SUE: 1.12 | # QB: 2
Revenue Correlation: 96.50 | Revenue CAGR: 11.95% | SUE: 1.16 | # QB: 1
EPS current Quarter (2026-11-30): EPS=1.87 | Chg30d=-0.72% | Revisions=+40% | Analysts=27
EPS next Quarter (2027-02-28): EPS=2.02 | Chg30d=-1.88% | Revisions=+40% | Analysts=34
EPS current Year (2027-05-31): EPS=8.14 | Chg30d=+1.09% | Revisions=+57% | GrowthEPS=+6.7% | GrowthRev=+34.3%
EPS next Year (2028-05-31): EPS=10.99 | Chg30d=+0.72% | Revisions=+57% | GrowthEPS=+35.0% | GrowthRev=+45.2%
[Analyst] Revisions Ratio: +80% (up=12, down=0)